Shaily Engineering Plastics Limited has announced its financial results for the first quarter of Fiscal Year 2027 (Q1 FY27). The company reported a 14% increase in revenue, reaching ₹280.7 crore compared to ₹246.7 crore in Q1 FY26. Profit After Tax (PAT) saw a substantial 17% rise to ₹48.0 crore. The investor presentation also highlighted business updates and key performance indicators for the quarter.
Shaily Engineering Plastics Reports Strong Q1 FY27 Performance
Shaily Engineering Plastics Limited has released its financial highlights for the first quarter ending June 30, 2026 (Q1 FY27). The company has demonstrated robust growth, with total revenues increasing by 14% year-on-year to ₹280.7 crore, up from ₹246.7 crore in the corresponding quarter of the previous fiscal year (Q1 FY26). This growth indicates a positive trajectory for the company’s operations.
Key Financial Metrics Show Upward Trend
In terms of profitability, Profit After Tax (PAT) for Q1 FY27 stood at ₹48.0 crore, marking a significant 17% increase from ₹41.1 crore in Q1 FY26. The EBITDA also saw a healthy rise of 18% to ₹83.3 crore. EBITDA margins improved by 120 basis points to 29.7%, and PAT margins expanded to 17.1%, up from 16.7% in the prior year’s quarter. Cash PAT also grew by 18% to ₹62.1 crore.
Business Updates and Segment Performance
The company’s investor presentation detailed significant business updates across its key segments: Healthcare, Consumer, and Industrial. In Healthcare, Shaily received customer approvals for Semaglutide pens in Canada/Brazil and signed two new projects for IP led platforms. The Consumer segment secured a global project from an FMCG customer and new projects in LED lights. The Industrial segment received business confirmations from Appliance, Consumer Electronics, and Automotive customers, including new parts for new consumer electronics and new automotive components.
The segment-wise revenue breakup shows that while the Consumer segment experienced a -24% decline to ₹115.5 crore due to weaker market demand for home furnishings, the Healthcare segment saw an impressive 85% surge to ₹142.4 crore. The Industrial segment also grew by 25% to ₹22.7 crore. The improved traction in the healthcare segment has been identified as the key driver for the overall business growth.
Operational and Capital Efficiency
Operationally, machine utilization across plants increased by 150 basis points to 50.2% in Q1 FY27. The revenue analysis also indicated a shift in the domestic-export mix, with exports rising to 58.1% in Q1 FY27 from 23.9% in Q1 FY26, primarily driven by the growing Healthcare business catering to global markets. The company also highlighted efficient use of capital, with Return on Capital Employed (ROCE) at 39.0% and Return on Equity (ROE) at 28.2% for June 2026 (annualized basis).
Source: BSE
